GENVAX TECHNOLOGIES INC
mRNA + nanoparticle vaccines for livestock
- Sector
- Biotech
- Headquarters
- AMES, IA
- Founded
- 2021
- Latest Form D
- $3.4M, Jun 2024
- Total capital
- $9.9M
- Federal grants
- $175K
- 1 award · 2023
- Rank in peer group#53 of 502
- Private capital raised
- $9.8M
- 2 Form D · last Jun 2024
- 28 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$3.4M
- Federal grantAgriculture · Swine Influenza A Virus (iav) Is A Highly Contagious Respiratory Virus That Is Endemic In Pigs Worldwide. Swine Iav Infections Represent An Enormous Economic Loss To Producers And Can Result In Acute Respiratory Disease And Severe Pathology When Acting In Concert With Other Pathogens. Zoonotic Transmissions Between Pigs And Humans Are A Threat To Both Human Health And Animal Production, With Spillover Events And Viral Evolution Leading To Increased Diversity. There Are Three Major Swine Iav Subt$175K
- Private capital raisedForm D · SEC · 1st filing$6.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grants#53 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- DL Hank HarrisDirectorNamed in SEC Form D filings
- Joel HarrisExecutive Officer, DirectorNamed in SEC Form D filings
- Scott HolmstromDirectorNamed in SEC Form D filings
- Trent TorranceDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingMethods Of Self-amplifying Rna-lipid Nanoparticle Manufacture And Compositions Derived TherefromUSPTOApplication 19294990
- PendingMethods Of Self-amplifying Rna-lipid Nanoparticle Manufacture And Compositions Derived TherefromUSPTOApplication 63681717
Related companies, and why
- Thunder Biotech, Inc.Similar federal contract value in Biotech · null in contracts
- Trait Biosciences Inc.Similar federal contract value in Biotech · null in contracts
- Core Quantum Technologies, Inc.Similar federal contract value in Biotech · null in contracts
- Pfenex Inc.Similar federal contract value in Biotech · null in contracts
- Mesentech Inc.Similar federal contract value in Biotech · null in contracts
- Aer TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .